Robert Azelby, Director at ADC Therapeutics SA (ADCT), sold 6,995 shares at $2.89 ($20K) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Open-market sale of $20k ADCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2018-02-09 | $600K | — | Filing → |
| JUNO | SELL | 2018-02-02 | $715K | — | Filing → |
| JUNO | SELL | 2018-01-24 | $17.7M | — | Filing → |